首页|布托啡诺联合腰方肌阻滞对结直肠癌患者术后镇痛及康复质量的影响

布托啡诺联合腰方肌阻滞对结直肠癌患者术后镇痛及康复质量的影响

扫码查看
目的 评价布托啡诺联合腰方肌阻滞(QLB)对结直肠癌患者术后镇痛及早期康复质量的影响。方法 选择择期全身麻醉下行腹腔镜结直肠癌根治术患者60例,随机分为2组,每组30例,2组麻醉诱导和维持方案相同。术后B组采用患者自控静脉镇痛(PCIA),镇痛液配方为布托啡诺0。2 mg·kg-1,用氯化钠注射液稀释至200mL;BQ组在B组基础上,在超声引导下行双侧前路QLB,双侧均注射0。25%罗哌卡因20mL。采用视觉模拟量表(VAS)与Bruggrmann舒适度量表(BCS)评估术后镇痛效果,检测术前、术后24h血清白细胞介素(IL)-6,C反应蛋白(CRP)及肿瘤坏死因子(TNF)-α浓度,评估患者术后康复情况及住院满意度评分,记录术后补救镇痛、不良反应发生情况。结果 术后2、6、12和24 h,BQ组VAS评分均显著低于B组(P<0。05),BCS评分均显著高于B组(P<0。05)。术后24h,2组的IL-6、TNF-α和CRP水平均显著高于术前(P<0。05),而BQ组显著低于B组(P<0。05)。与B组相比,BQ组术后肛门排气时间、进流质食物时间、下床活动时间和住院时间均显著缩短(P<0。05),住院满意度显著增高(P<0。05)。BQ组术后48 h内布托啡诺消耗量少于B组,补救镇痛率低于B组,均有显著差异(P<0。05)。2组均无严重不良反应发生,但恶心呕吐发生率BQ组显著低于B组(P<0。05)。结论 布托啡诺联合QLB用于腹腔镜结直肠癌根治术患者术后镇痛,可以有效增强术后镇痛效果,减轻机体炎症反应,促进患者早期康复。
Effects of butorphanol combined with quadratus lumborum block on postoperative analgesia and rehabilitation quality in patients with colorectal cancer
AIM To evaluate the effects of butorphanol combined with quadratus lumborum block(QLB)on postoperative analgesia and early rehabilitation quality in patients with colorectal cancer.METHODS Sixty patients undergoing elective laparoscopic radical resection of colorectal cancer under general anesthesia were randomly divided into two groups,with 30 cases in each group.The induction and maintenance of anesthesia were the same in the two groups.Patients in group B received patient-controlled intravenous analgesia(PCIA)with butorphanol 0.2 mg·kg-1 diluted to 200 mL with sodium chloride injection.Patients in group BQ received ultrasound-guided bilateral anterior QLB and 0.25%ropivacaine 20 mL was injected bilaterally on the basis of that in the group B.Visual analogue scale(VAS)and Bruggrmann comfort scale(BCS)were used to evaluate the analgesic effect of the two groups after operation.The serum levels of interleukin(IL)-6,C-reactive protein(CRP)and tumor necrosis factor(TNF)-α were detected before operation and 24 h after operation.The postoperative recovery and hospitalization satisfaction score of the patients were evaluated,the consumption of butorphanol and the requirement for rescue analgesia within 48 h after operation were recorded,and the occurrence of postoperative nausea and vomiting was observed.RESULTS The VAS scores of the group BQ were lower than those of the group B at 2,6,12 and 24 h after operation(P<0.05),and the BCS scores of the group BQ were higher than those of the group B(P<0.05).The levels of IL-6,TNF-α and CRP at 24 h after operation in both groups were higher than those before operation(P<0.05),but those in the group BQ were lower than those in the group B(P<0.05).The postoperative anal exhaust time,liquid food intake time,ambulation time and hospitalization time in the group BQ were shorter than those in the group B(P<0.05),and the hospitalization satisfaction in the group BQ was higher than that in the group B(P<0.05).The consumption of butorphanol within 48 h after operation in the group BQ was less than that in the group B(P<0.05),and the requirement for rescue analgesia in the group BQ was lower than that in the group B(P<0.05).No serious adverse reactions occurred in the two groups,but the incidence of nausea and vomiting in the group BQ was significantly lower than that in the group B(P<0.05).CONCLUSION Butorphanol combined with QLB for postoperative analgesia in patients undergoing laparoscopic radical resection of colorectal cancer can effectively enhance the postoperative analgesic effect,reduce the inflammatory response of the body,and promote the early recovery of patients.

butorphanolanalgesiacolorectal neoplasmscolorectal surgeryenhanced recover after surgeryquadratus lumborum block

王金忠、韩硕、沈社良、许佳、王旭璐

展开 >

杭州市第九人民医院麻醉科,浙江杭州 311225

浙江省人民医院麻醉科,浙江杭州 310014

布托啡诺 镇痛 结直肠肿瘤 结直肠外科手术 术后加速康复 腰方肌阻滞

浙江省医学会临床科研基金

2021ZYC-A90

2024

中国新药与临床杂志
中国药学会 上海市食品药品监督管理局科技情报研究所

中国新药与临床杂志

CSTPCD北大核心
影响因子:0.967
ISSN:1007-7669
年,卷(期):2024.43(5)
  • 17